Cancer, a dreadful disease that is feared for the sheer number of lives it claims, may soon be eradicated. A medication trial at Memorial Sloan Kettering Cancer Center in Manhattan, New York, has proven 100 percent cancer eradication in patients for the first time.
A small-scale trial of a cancer treatment medicine revealed that it was completely successful in eliminating tumors and preventing recurrence in patients. According to specialists, this is the first time in medical history that something like this has happened.
According to The New York Times, the treatment — dostarlimab — was given to 18 rectal cancer patients, all of whom appeared to have recovered entirely because the disease could not be detected by physical examination, endoscopy, PET, or MRI scans.
- Nearly 10 million people will die in 2020, according to the World Health Organization. Cancer was responsible for approximately one out of every six deaths.
- Breast cancer was the leading cause of new cases (2.26 million), with lung cancer a close second (2.21 million).
- ‘Checkpoint inhibitors,’ as these pharmaceuticals are known, usually cause some sort of side effect in 20% of individuals who use them. Nearly 60% of individuals experience serious consequences, such as muscular weakness. However, none of the individuals in the dostarlimab research had a negative reaction.
- The medicine would not be cheap if it is approved for widespread use in the future; trial doses cost $11,000 each, or almost Rs 8.55 lakh per dose.
- Furthermore many more trials are bound to take place .
